bmi and clinical outcomes in patients with metastatic castration-resistant prostate cancer
Published 3 years ago • 109 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
1:33
fih study of arv-110 in metastatic castrate-resistant prostate cancer
-
1:10
treatment options for patients with metastatic castration-resistant prostate cancer
-
1:29
evaluating the role of sbrt in metastatic castrate-resistant prostate cancer
-
16:39
metastatic castration resistant prostate cancer (mcrpc) – inroads in improved outcomes
-
8:47
examining metastatic castration-resistant prostate cancer treatment in black patients
-
0:58
biomarkers associated with parpi response in patients with castration-resistant prostate cancer
-
22:16
understanding non metastatic castration resistant prostate cancer with dr. hamilton
-
5:01
fda d.i.s.c.o.: a new drug approval for non-metastatic castration-resistant prostate cancer
-
5:46
metastatic castration-resistant prostate cancer – new learnings and perspectives
-
33:19
castration resistant prostate cancer - developments and challenges from 2020
-
5:41
diagnosing and treating castration resistant prostate cancer
-
1:15
updates in the treatment of castration-resistant prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
4:46
quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
-
7:17
understanding metastatic castration-resistant prostate cancer
-
3:48
olaparib zytiga for metastatic castrate-resistant prostate cancer | learn about clinical trials
-
3:56
about metastatic castrate-resistant prostate cancer
-
7:50
advancements in the treatment and management of patients with castration resistant prostate cancer